Table of contents
Happy April, all.
We know that technology leaders, the C-Suite, and Boards of Directors are thinking about how to adopt AI effectively and responsibly.
For investor-backed tech companies in particular, we’re hearing it is critical to adopt AI the right way to prepare for a future successful exit.
Sema has started building a library of AI Working Papers to help.
- Working Paper (WP) 01: High ROI AI Activities. Shares six areas where it likely makes sense to invest now in AI tools based on benefit, ongoing cost, and setup costs.
- WP 02: Assessing IP Risks of Coders Using GenAI. Discusses the pathway for intellectual property protection of code when coders use GenAI tools.
- WP 03: Comparison of tiers of GitHub Copilot GenAI Coding Tools. Illustrates a critical method to reduce risks from coders using GenAI tools — managing access to the appropriate tools, in this case from within Microsoft’s suite.
- WP 04: Risk and Benefit Assessment from GenAI Coding Tools. In short, the benefits outweigh the risks and implementation costs of providing developers with GenAI tools.
You can drop us a line if you’d like to read any or all of them by contacting us here.
About Sema Technologies, Inc.
Sema is the leader in comprehensive codebase scans with over $1T of enterprise software organizations evaluated to inform our dataset. We are now accepting pre-orders for AI Code Monitor, which translates compliance standards into “traffic light warnings” for CTOs leading fast-paced and highly productive engineering teams.
Disclosure
Sema publications should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only. To request reprint permission for any of our publications, please use our “Contact Us” form. The availability of this publication is not intended to create, and receipt of it does not constitute, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.